Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2014 2
2015 1
2016 5
2017 3
2018 2
2019 6
2020 7
2021 8
2022 6
2023 7
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Bringing an end to diabetes stigma and discrimination: an international consensus statement on evidence and recommendations.
Speight J, Holmes-Truscott E, Garza M, Scibilia R, Wagner S, Kato A, Pedrero V, Deschênes S, Guzman SJ, Joiner KL, Liu S, Willaing I, Babbott KM, Cleal B, Dickinson JK, Halliday JA, Morrissey EC, Nefs G, O'Donnell S, Serlachius A, Winterdijk P, Alzubaidi H, Arifin B, Cambron-Kopco L, Santa Ana C, Davidsen E, de Groot M, de Wit M, Deroze P, Haack S, Holt RIG, Jensen W, Khunti K, Kragelund Nielsen K, Lathia T, Lee CJ, McNulty B, Naranjo D, Pearl RL, Prinjha S, Puhl RM, Sabidi A, Selvan C, Sethi J, Seyam M, Sturt J, Subramaniam M, Terkildsen Maindal H, Valentine V, Vallis M, Skinner TC. Speight J, et al. Among authors: holmes truscott e. Lancet Diabetes Endocrinol. 2024 Jan;12(1):61-82. doi: 10.1016/S2213-8587(23)00347-9. Lancet Diabetes Endocrinol. 2024. PMID: 38128969 Review.
Challenging diabetes stigma starts and ends with all of us.
Speight J, Holmes-Truscott E. Speight J, et al. Among authors: holmes truscott e. Lancet Diabetes Endocrinol. 2023 Jun;11(6):380-382. doi: 10.1016/S2213-8587(23)00084-0. Epub 2023 Apr 17. Lancet Diabetes Endocrinol. 2023. PMID: 37080229 No abstract available.
Do governments give diabetes the attention it deserves?
Speight J, Holmes-Truscott E. Speight J, et al. Among authors: holmes truscott e. Diabet Med. 2024 Jan;41(1):e15186. doi: 10.1111/dme.15186. Epub 2023 Jul 27. Diabet Med. 2024. PMID: 37470757 No abstract available.
Living between two worlds: lessons for community involvement.
Ng AH, Quigley M, Benson T, Cusack L, Hicks R, Nash B, Read M, Scibilia R, Steele C, Tribe L, Holmes-Truscott E. Ng AH, et al. Among authors: holmes truscott e. Lancet Diabetes Endocrinol. 2024 Mar;12(3):155-157. doi: 10.1016/S2213-8587(24)00032-9. Lancet Diabetes Endocrinol. 2024. PMID: 38388070 No abstract available.
'For me, it didn't seem as drastic a step as being controlled by insulin': A qualitative investigation of expectations and experiences of non-insulin injectable therapy among adults with type 2 diabetes.
Holmes-Truscott E, Schipp J, Dunning T, Furler J, Hagger V, Holloway EE, Manski-Nankervis JA, Shaw JE, Skinner T, Speight J. Holmes-Truscott E, et al. Diabet Med. 2022 Feb;39(2):e14681. doi: 10.1111/dme.14681. Epub 2021 Sep 4. Diabet Med. 2022. PMID: 34465005
Cost-effectiveness of professional-mode flash glucose monitoring in general practice among adults with type 2 diabetes: Evidence from the GP-OSMOTIC trial.
Hua X, Catchpool M, Clarke P, Blackberry I, Chiang J, Holmes-Truscott E, Jenkins A, Khunti K, O'Neal D, Speight J, Furler J, Manski-Nankervis JA, Dalziel K; GP-OSMOTIC Study Group. Hua X, et al. Among authors: holmes truscott e. Diabet Med. 2022 Mar;39(3):e14747. doi: 10.1111/dme.14747. Epub 2021 Nov 27. Diabet Med. 2022. PMID: 34806780 Clinical Trial.
45 results